CH611910A5 - - Google Patents

Info

Publication number
CH611910A5
CH611910A5 CH1020975A CH1020975A CH611910A5 CH 611910 A5 CH611910 A5 CH 611910A5 CH 1020975 A CH1020975 A CH 1020975A CH 1020975 A CH1020975 A CH 1020975A CH 611910 A5 CH611910 A5 CH 611910A5
Authority
CH
Switzerland
Application number
CH1020975A
Inventor
Otto Dr Engelfried
Ulrich Dr Kerb
Rudolf Prof Dr Wiechert
Helmut Dr Wachtel
Dieter Dr Palenschat
Reinhard Dr Horowski
Gert Dr Paschelke
Wolfgang Dr Kehr
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of CH611910A5 publication Critical patent/CH611910A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
CH1020975A 1974-08-05 1975-08-05 CH611910A5 (OSRAM)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2438020A DE2438020A1 (de) 1974-08-05 1974-08-05 18-methyl-19-nor-20-keto-pregnane und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
CH611910A5 true CH611910A5 (OSRAM) 1979-06-29

Family

ID=5922668

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1020975A CH611910A5 (OSRAM) 1974-08-05 1975-08-05

Country Status (17)

Country Link
US (1) US4029777A (OSRAM)
JP (1) JPS5141347A (OSRAM)
AT (1) AT345998B (OSRAM)
BE (1) BE832124A (OSRAM)
CA (1) CA1037027A (OSRAM)
CH (1) CH611910A5 (OSRAM)
CS (2) CS175498B2 (OSRAM)
DD (1) DD120192A5 (OSRAM)
DE (1) DE2438020A1 (OSRAM)
DK (1) DK136369C (OSRAM)
ES (1) ES439720A1 (OSRAM)
FR (1) FR2281123A1 (OSRAM)
GB (1) GB1512258A (OSRAM)
HU (1) HU171684B (OSRAM)
IL (1) IL47770A (OSRAM)
NL (1) NL7509326A (OSRAM)
SE (1) SE404804B (OSRAM)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61144199A (ja) * 1984-12-18 1986-07-01 Pioneer Electronic Corp スピ−カ用紙製振動部材の製造方法
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
WO1989002272A1 (en) * 1987-08-25 1989-03-23 Gee Kelvin W Compositions and methods for alleviating stress, anxiety and seizure activity
US5175154A (en) * 1987-11-25 1992-12-29 Research Corporation Technologies, Inc. 5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds
CN108440633B (zh) 2013-04-17 2021-07-13 萨奇治疗股份有限公司 19-去甲c3,3-二取代的c21-n-吡唑基类固醇及其使用方法
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
RS60420B1 (sr) 2013-04-17 2020-07-31 Sage Therapeutics Inc 19-nor neuroaktivni steroidi za metode lečenja
HUE053900T2 (hu) 2013-07-19 2021-07-28 Sage Therapeutics Inc Neuroaktív szteroidok, kompozíciók, és azok alkalmazásai
BR112016003862B1 (pt) 2013-08-23 2022-09-06 Sage Therapeutics, Inc Compostos esteroides neuroativos, suas composições e seus usos
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
JP6909155B2 (ja) 2014-10-16 2021-07-28 セージ セラピューティクス, インコーポレイテッド Cns障害を処置するための組成物および方法
SI3206493T1 (sl) 2014-10-16 2020-10-30 Sage Therapeutics, Inc. Sestavki in metode za zdravljenje CNS motenj
ES2793237T3 (es) 2014-11-27 2020-11-13 Sage Therapeutics Inc Composiciones y métodos para el tratamiento de trastornos del SNC
SI3250210T1 (sl) 2015-01-26 2021-07-30 Sage Therapeutics, Inc. Sestavki in metode za zdravljenje CNS motenj
ES2935476T3 (es) 2015-02-20 2023-03-07 Sage Therapeutics Inc Esteroides neuroactivos, composiciones y usos de los mismos
US20190233465A1 (en) 2016-07-11 2019-08-01 Sage Therapeutics, Inc. C7, c12, and c16 substituted neuroactive steroids and their methods of use
EP3481845B1 (en) 2016-07-11 2023-09-13 Sage Therapeutics, Inc. C17, c20, and c21 substituted neuroactive steroids and their methods of use
ES2991092T3 (es) * 2017-12-22 2024-12-02 Sage Therapeutics Inc Compuestos 19-homo, 3-alfa-hidroxi-esteroides-20-ona para el tratamiento de trastornos del SNC
PH12021553005A1 (en) 2019-05-31 2023-08-14 Sage Therapeutics Inc Neuroactive steroids and compositions thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1409239A (en) * 1971-11-11 1975-10-08 Glaxo Lab Ltd Process for the preparation of 3alpha-hydroxy-5alpha-steroids
BE791196A (fr) * 1971-11-11 1973-05-10 Glaxo Lab Ltd Nouveaux steroides, leur procede de preparation et leurs applications

Also Published As

Publication number Publication date
GB1512258A (en) 1978-05-24
AT345998B (de) 1978-10-10
DK136369B (da) 1977-10-03
SE7508777L (sv) 1976-02-06
CS175498B2 (OSRAM) 1977-05-31
NL7509326A (nl) 1976-02-09
AU8351575A (en) 1977-02-03
CS175500B2 (OSRAM) 1977-05-31
US4029777A (en) 1977-06-14
IL47770A0 (en) 1975-10-15
DD120192A5 (OSRAM) 1976-06-05
DK344475A (da) 1976-02-06
IL47770A (en) 1978-10-31
ATA600475A (de) 1978-02-15
CA1037027A (en) 1978-08-22
FR2281123A1 (fr) 1976-03-05
SE404804B (sv) 1978-10-30
DE2438020A1 (de) 1976-02-26
JPS5141347A (en) 1976-04-07
HU171684B (hu) 1978-02-28
BE832124A (fr) 1976-02-05
ES439720A1 (es) 1977-03-01
DK136369C (da) 1978-02-27

Similar Documents

Publication Publication Date Title
FR2258657A1 (OSRAM)
CS175498B2 (OSRAM)
FR2259909A1 (OSRAM)
FR2259461B3 (OSRAM)
FR2257180B1 (OSRAM)
FR2256753A1 (OSRAM)
FR2259932B3 (OSRAM)
AU6717074A (OSRAM)
AU7099174A (OSRAM)
FR2257572A1 (OSRAM)
FR2259267A1 (OSRAM)
BG20443A1 (OSRAM)
AU481340A (OSRAM)
BG20424A1 (OSRAM)
BG20419A2 (OSRAM)
BG20230A1 (OSRAM)
BG20164A1 (OSRAM)
BG20145A1 (OSRAM)
BG19962A1 (OSRAM)
BG19932A1 (OSRAM)
BG19893A1 (OSRAM)
BG19816A1 (OSRAM)
BG20709A1 (OSRAM)
BG20464A1 (OSRAM)
BG20468A1 (OSRAM)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased